LIGAND PHARMACEUTICALS INC — Director's Dealing 2017

Dec 21, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2017-12-20

Reporting Person: Sabba Stephen L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-12-20	Common Stock	S	925	$137.25	Disposed	26985	Direct

Footnotes

F1: These securities, as represented in Column 5 and as previously reported in the Form 4 filed for this Reporting Person on May 30, 2017, include a grant of 666 restricted shares approved by the Board of Directors of the Company at the 2017 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.